Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Tara C. Gangadhar, MD

Tara C. Gangadhar, MD Physician

Assistant Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Gangadhar is a Penn Medicine employed physician.

Clinical Specialties

Specialty:

  • Medicine
    • Medical Oncology

Programs & Centers:

Board Certification:

  • Internal Medicine, 2007
  • Medical Oncology, 2010

Clinical Expertise:

  • Melanoma
  • Skin Cancer

Description of Clinical Expertise

Melanoma
Cutaneous malignancies
Gastroinitestinal malignancies

Practice Locations and Appointments

  • Abramson Cancer Center

    Perelman Center for Advanced Medicine West Pavilion, 4th Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-PENN (7366)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Residency: Indiana University Hospital
Fellowship: University of Chicago Medical Center

Memberships

Abramson Cancer Center of the University of Pennsylvania, National American Society of Clinical Oncology, National American Society of Clinical Pharmacology and Therapeutics, National Melanoma Research Foundation Breakthrough Consortium, National Penn Institute for Immunolology, Local Society for Melanoma Research, International

Hospital Affiliation

Dr. Gangadhar is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Description of Research Expertise:

Melanoma
Immune therpay
Targeted therapy
Phase I trials
Combination therapy
Experimental therapeutics
Pharmacology

Selected Publications:

Hodi F Stephen, Hwu Wen-Jen, Kefford Richard, Weber Jeffrey S, Daud Adil, Hamid Omid, Patnaik Amita, Ribas Antoni, Robert Caroline, Gangadhar Tara C, Joshua Anthony M, Hersey Peter, Dronca Roxana, Joseph Richard, Hille Darcy, Xue Dahai, Li Xiaoyun Nicole, Kang S Peter, Ebbinghaus Scot, Perrone Andrea, Wolchok Jedd D: Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 34 (13): 1510-7,2016.

Ribas Antoni, Hamid Omid, Daud Adil, Hodi F Stephen, Wolchok Jedd D, Kefford Richard, Joshua Anthony M, Patnaik Amita, Hwu Wen-Jen, Weber Jeffrey S, Gangadhar Tara C, Hersey Peter, Dronca Roxana, Joseph Richard W, Zarour Hassane, Chmielowski Bartosz, Lawrence Donald P, Algazi Alain, Rizvi Naiyer A, Hoffner Brianna, Mateus Christine, Gergich Kevin, Lindia Jill A, Giannotti Maxine, Li Xiaoyun Nicole, Ebbinghaus Scot, Kang S Peter, Robert Caroline: Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma. JAMA 315 (15): 1600-9,2016.

Zhang Gao, Frederick Dennie T, Wu Lawrence, Wei Zhi, Krepler Clemens, Srinivasan Satish, Chae Young Chan, Xu Xiaowei, Choi Harry, Dimwamwa Elaida, Ope Omotayo, Shannan Batool, Basu Devraj, Zhang Dongmei, Guha Manti, Xiao Min, Randell Sergio, Sproesser Katrin, Xu Wei, Liu Jephrey, Karakousis Giorgos C, Schuchter Lynn M, Gangadhar Tara C, Amaravadi Ravi K, Gu Mengnan, Xu Caiyue, Ghosh Abheek, Xu Weiting, Tian Tian, Zhang Jie, Zha Shijie, Liu Qin, Brafford Patricia, Weeraratna Ashani, Davies Michael A, Wargo J: Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors. The Journal of clinical investigation : 2016.

Shannan Batool, Chen Quan, Watters Andrea, Perego Michela, Krepler Clemens, Thombre Rakhee, Li Ling, Rajan Geena, Peterson Scott, Gimotty Phyllis A, Wilson Melissa, Nathanson Katherine L, Gangadhar Tara C, Schuchter Lynn M, Weeraratna Ashani T, Herlyn Meenhard, Vultur Adina: Enhancing the evaluation of PI3K inhibitors through 3D melanoma models. Pigment cell & melanoma research 29 (3): 317-28,2016.

Dizon Don S, Krilov Lada, Cohen Ezra, Gangadhar Tara, Ganz Patricia A, Hensing Thomas A, Hunger Stephen, Krishnamurthi Smitha S, Lassman Andrew B, Markham Merry Jennifer, Mayer Erica, Neuss Michael, Pal Sumanta Kumar, Richardson Lisa C, Schilsky Richard, Schwartz Gary K, Spriggs David R, Villalona-Calero Miguel Angel, Villani Gina, Masters Gregory: Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 34 (9): 987-1011,2016.

Shah Nirav N, Casella Erica, Capozzi Donna, McGettigan Suzanne, Gangadhar Tara C, Schuchter Lynn, Myers Jennifer S: Improving the Safety of Oral Chemotherapy at an Academic Medical Center. Journal of oncology practice / American Society of Clinical Oncology 12 (1): e71-6,2016.

Shin Thuzar M, Gangadhar Tara, Miller Christopher J: Treatment options for metastatic melanoma in solid organ transplant recipients. JAAD case reports 1 (6): S26-8,2015.

Sholl Lynette M, Andea Aleodor, Bridge Julia A, Cheng Liang, Davies Michael A, Ehteshami Mani, Gangadhar Tara C, Kamel-Reid Suzanne, Lazar Alexander, Raparia Kirtee, Siroy Alan, Watson Kimberly L: Template for Reporting Results of Biomarker Testing of Specimens From Patients With Melanoma. Archives of pathology & laboratory medicine 140 (4): 355-7,2015.

Ribas Antoni, Puzanov Igor, Dummer Reinhard, Schadendorf Dirk, Hamid Omid, Robert Caroline, Hodi F Stephen, Schachter Jacob, Pavlick Anna C, Lewis Karl D, Cranmer Lee D, Blank Christian U, O'Day Steven J, Ascierto Paolo A, Salama April K S, Margolin Kim A, Loquai Carmen, Eigentler Thomas K, Gangadhar Tara C, Carlino Matteo S, Agarwala Sanjiv S, Moschos Stergios J, Sosman Jeffrey A, Goldinger Simone M, Shapira-Frommer Ronnie, Gonzalez Rene, Kirkwood John M, Wolchok Jedd D, Eggermont Alexander, Li Xiaoyun Nic: Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial. The Lancet. Oncology 16 (8): 908-18,2015.

Gangadhar Tara C, Schuchter Lynn M: Broad Applicability of Nivolumab in Melanoma Regardless of BRAF Mutation Status. JAMA oncology 1 (4): 427-8,2015.

View all publications

Academic Contact Info

3400 Civic Center Blvd.
South Pavilion, 7th Floor

Philadelphia, PA 19104
Phone: (215) 662-7907
Fax: (215) 662-4646
Patient appointments: 800-789-PENN (7366)